Sicart Associates’s CG Oncology CGON Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $650K | Hold |
25,000
| – | – | 0.23% | 45 |
|
|
2025
Q1 | $612K | Hold |
25,000
| – | – | 0.21% | 46 |
|
|
2024
Q4 | $717K | Hold |
25,000
| – | – | 0.26% | 46 |
|
|
2024
Q3 | $943K | Hold |
25,000
| – | – | 0.33% | 45 |
|
|
2024
Q2 | $789K | Hold |
25,000
| – | – | 0.3% | 46 |
|
|
2024
Q1 | $1.1M | Buy |
+25,000
| New | +$1.1M | 0.4% | 46 |
|